Clinical Trials Logo

Fatigue clinical trials

View clinical trials related to Fatigue.

Filter by:

NCT ID: NCT03000777 Completed - Clinical trials for Fatigue Syndrome, Chronic

Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)

MELATOZINC
Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effects of oral melatonin plus zinc supplementation in relieving self-reported fatigue in CFS/ME

NCT ID: NCT03000166 Completed - Clinical trials for Young Adult, Cancer, Physical Activity

Step-Up Intervention for Self-Management of Fatigue in Young Adults Receiving Chemotherapy

Start date: January 31, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the impact of a physical activity intervention on the self-management of fatigue in young adults receiving chemotherapy. Half of the participants will receive an intervention which includes education and resources to set physical activity goals and monitor progress toward goals.

NCT ID: NCT03000127 Withdrawn - Multiple Sclerosis Clinical Trials

Testosterone for Fatigue in Men With MS

Start date: July 1, 2018
Phase: Phase 2
Study type: Interventional

Fatigue is a major symptom in people with multiple sclerosis (MS), for which treatments are limited. Several studies have shown that a large proportion of men with MS have low testosterone levels. We propose a two-site clinical trial using topical testosterone gel as a treatment for MS-related fatigue in men with progressive MS who have low or low-normal testosterone levels.

NCT ID: NCT02996786 Completed - Inflammation Clinical Trials

Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners

Start date: October 2016
Phase: N/A
Study type: Interventional

The aim of this study is to examine the beneficial effects of Danggui Buxue Tang on blood biochemical parameters in male recreational runners.

NCT ID: NCT02987621 Completed - Multiple Sclerosis Clinical Trials

Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS?

Start date: November 2016
Phase: N/A
Study type: Interventional

In this project the investigators will be using non-invasive brain stimulation on people with multiple sclerosis (PwMS) to improve leg muscle function. Two groups of participants will be recruited. One group will perform strength testing with and without the brain stimulation. The second group of participants will perform a fatigue task, pulling against a wire at a low level of force, with and without the brain stimulation. This type of brain stimulation has been shown to transiently improve strength and fatigue measures in other populations, e.g. aged, Parkinson's, and improve cognitive abilities in people with multiple sclerosis. It is the investigator's hope that the increases in performance seen in other patient groups will also occur in people with multiple sclerosis. Future investigations will look to apply the non-invasive brain stimulation technique during physical rehabilitation to improve short and long term outcomes related to physical function.

NCT ID: NCT02986555 Recruiting - Clinical trials for Stress, Psychological

Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation

Start date: December 2016
Phase: N/A
Study type: Interventional

Current virtual reality device makes motion sickness and visual fatigue having limitation for recreation and other clinical approaches. Still there is no standardized quantification of motion sickness and visual fatigue measurement with objective approach. Current biofeedback accompanied with virtual reality would be promising tool for stress relief.

NCT ID: NCT02977845 Completed - Clinical trials for Lung Cancer, Nonsmall Cell

Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Effects of Qigong on symptom clusters of dyspnea, fatigue, and anxiety in Vietnamese lung cancer patients: A randomized control trial

NCT ID: NCT02970240 Completed - Clinical trials for Chronic Fatigue Syndrome

Cardiopulmonary Testing in ME/CFS to Improve Diagnostic Accuracy

Start date: June 2014
Phase:
Study type: Observational

Circumstantial evidence suggests that patients diagnosed with myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) perform worse on day 2 in a 2-day consecutive cardiopulmonary exercise test (CPET). The aim of this study is to examine if CPET can distinguish between ME/CFS patients and healthy controls.

NCT ID: NCT02965768 Withdrawn - Clinical trials for Fatigue Syndrome, Chronic

Immune Effects of Low-dose Naltrexone in ME/CFS

Start date: January 2016
Phase: N/A
Study type: Interventional

The main objective of this study is to test if naltrexone, when taken in low doses, has an anti-inflammatory effect that may be associated with positive clinical outcomes in people with chronic fatigue syndrome (CFS). In part, the present study, is a continuation of prior work in which we showed that chronic fatigue symptoms are associated with immune activity, and that low-dose naltrexone might exert anti-inflammatory effects in fibromyalgia, which is thought to share some pathophysiological and clinical characteristics with CFS.

NCT ID: NCT02964533 Recruiting - Clinical trials for Chronic Fatigue Syndrome

Thunder-Fire Moxibustion Therapy for Chronic Fatigue Syndrome on Shenque Acupoint: a Randomized Controlled Trial

Start date: November 2016
Phase: N/A
Study type: Interventional

Chronic fatigue syndrome is a group of syndrome and is prevalent in adult. Thunder-fire moxibustion is a commentary therapy belonged to acupuncture therapy. To evaluate the effect and safety of thunder-fire moxibustion therapy for chronic fatigue syndrome, we apply a randomized controlled trial by recruiting chronic fatigue syndrome patient as subject, applying thunder-fire moxibustion on shenque acupoint contrasted to common moxa-stick moxibustion, taking fatigue rating scale score, the content of CD3+、CD4+、CD8+、CD4+/CD8+ as evaluation indexes. The treatment time is 20-30 minutes per session, 3-4 times a week, there are totally 15 sessions.